PZPeng Zhao

Peng Zhao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Peng Zhao has a total of 69 co-authors. Here are the top co-authors by number of shared publications:

  • Xingang Li

    Department of Neurosurgery, Qilu Hospital, Cheeloo College of Medicine and Institute of Brain and Brain-Inspired Science, Shandong University, Jinan, China

    7 shared publications
  • Anjing Chen

    Department of Neurosurgery, Qilu Hospital of Shandong University and Brain Science Research Institute, Shandong University, Jinan 250012, China

    3 shared publications
  • Qing Zhang

    Department of Neurosurgery, Qilu Hospital of Shandong University and Brain Science Research Institute, Shandong University, Jinan 250012, China

    3 shared publications
  • Wenjie Li

    Department of Neurosurgery, Qilu Hospital of Shandong University and Brain Science Research Institute, Shandong University, Jinan 250012, China

    3 shared publications
  • Bing Huang

    Department of Neurosurgery, Qilu Hospital of Shandong University and Brain Science Research Institute, Shandong University, Jinan 250012, China

    2 shared publications
  • Donghai Wang

    Department of Neurosurgery, Qilu Hospital of Shandong University, Jinan, China

    2 shared publications

Latest Publications

  • Open Access

    Single‐Cell Transcriptomics of Human Pericarotid Lymph Nodes Indicating Stability of Carotid Atherosclerotic Plaques

    by Tao Sun, Yanzhao Wu, Guohao Liu, Zhiwei Xue, Mengchen Yu, Bo Mao, Mengtao Han, Xiangjun Liang, Lu Ling, Nanlin You, et al.

    Background: The link between lymph node (LN) function and atherosclerosis is unclear, especially at the single‐cell level. This study explores the relationship between pericarotid LNs and plaque stability using single‐cell transcriptome analysis. Methods: We enrolled 106 patients with severe internal carotid artery stenosis undergoing carotid endarterectomy. We recorded baseline clinical data and pericarotid LN size, and analyzed plaque composition to assess its association with enlarged LNs. Single‐cell transcriptome and T/B‐cell receptor sequencing were used to profile pericarotid LNs. Results: Patients with symptomatic carotid atherosclerosis had more enlarged pericarotid LNs ( P + macrophage infiltration ( P P P <0.001), suggesting heightened immune response. Macrophages and neutrophils may help in cholesterol transport and degradation, while stromal cells may regulate the immune microenvironment by influencing T‐cell tolerance and lymphocyte trafficking. Conclusions: Enlarged pericarotid LNs are potential biomarkers for plaque instability and recent ischemic events. This study provides a comprehensive single‐cell transcriptomic landscape of human LNs in atherosclerosis.


  • Open Access

    Clinical prognosis of adult moyamoya disease patients after direct bypass surgery

    by Yun Qian, Zongmin Hu, Yu Cui, Ting-Ting Zou, Peng Zhao

    Background This study aimed to identify the factors affecting the patency of the bridging vessels and the improvement of postoperative neurological function, so as to enable the prediction of the influence on vascular bypass before operation and to guide the selection of surgical strategies. Methods We used Logistic regression analysis to determine if the following factors were related to the patency of the bypass: age, sex, smoking history, drinking, diabetes, hypertension, history of pre-operation cerebral infarction, transient ischemic attack (TIA), clinical classification of moyamoya disease (MMD), clinical manifestations, preoperative modified Rankin Scale mRS score, and Suzuki staging (operative side, non-operative side, and posterior circulation involvement). Base on this, we can explore the related factors affecting the vascular patency and prognosis. The symptom improvement data at discharge, 6 months after discharge and 2 years after discharge after bypass surgery in adult patients with MMD disease through outpatient or telephone follow-up were collected. The postoperative neurological function through mRS score was evaluated. After that, the linear mixed effect model was used to analyze the effects of related factors on the changes of mRS score. Results There is a significant difference between hypertension history and indirect bridging angiogenesis in the grade of direct bridging angiogenesis (P < 0.05). Logistic regression analysis further confirmed that hypertension (OR:0.24, 95% CI: 0.10–0.56) was a risk factor affecting direct bridge angiogenesis after operation. Compared with grade 0 of direct bridge vessels, grade II vascular patency was related to the decrease of indirect angiogenesis (OR:0.14, 95% CI:0.03–0.64), but the results of trend test showed that indirect bridge angiogenesis decreased with the increase of grade (P = 0.030). The follow-up data (250 cases) were processed by linear mixed effect model. The study found that despite the risk of intracranial hemorrhage in patients with hyperperfusion, the neurological function recovered relatively quickly; The neurological function of patients with cerebral infarction after operation is generally poor, but the recovery speed is relatively fast, and the prognosis is still worse than that of patients without cerebral infarction. Conclusions Patients with hypertension are prone to direct bridge vascular occlusion after operation; Direct bridge angiogenesis after operation is better, which will inhibit indirect bridge angiogenesis. Patients with high perfusion after operation have large blood flow. Although they have the risk of bleeding, their neurological function recovers relatively quickly; Although the recovery rate of patients with postoperative cerebral infarction is relatively fast, the prognosis is still poor.

  • Open Access

    Quantitative study of bioinformatics analysis on glioma: a bibliometric analysis

    by Xiaobing Yang, Dulegeqi Man, Peng Zhao, Xingang Li

    Background: The bioinformatics analysis on glioma has been a hot point recently. The purpose of this study was to provide an overview of the research in this field using a bibliometric method.Methods: The Web of Science Core Collection (WOSCC) database was used to search for literature related to the bioinformatics analysis of gliomas. Countries, institutions, authors, references, and keywords were analyzed using VOSviewer, CiteSpace, and Microsoft Excel software.Result: China was the most productive country, while the USA was the most cited. Capital Medical University had the largest number of publications and citations. Institutions tend to collaborate more with other institutions in their countries rather than foreign ones. The most productive and most cited author was Jiang Tao. Two citation paths were identified, with literature in basic research journals often cited in clinical journals. Immune-related vocabularies appeared frequently in recent studies.Conclusion: Glioma bioinformatics analyses spanned a wide range of fields. The international communication in this field urgently needs to be strengthened. Glioma bioinformatics approaches are developing from basic research to clinical applications. Recently, immune-related research has become a focus.


  • Identification of the therapeutic mechanism of the saffron crocus on glioma through network pharmacology and bioinformatics analysis

    by Xiaobing Yang, Dulegeqi Man, Peng Zhao, Xingang Li

    Saffron crocus is a herbal medicine of traditional Tibetan medicine (TTM). Saffron extract has been indicated to inhibit tumor cell growth and promote tumor cell apoptosis in a variety of cancers, including glioma, but the specific mechanism is not clear. To study the possible mechanism of saffron action on glioma, network pharmacology and bioinformatics analysis methods were used in this study. We used the online database to obtain the active ingredients of saffron and their targets. Glioma-related targets were also acquired from online database. We intersected drug targets with glioma-related targets and conducted PPI network analysis to obtain network core genes. Then, we obtained RNA-seq data from The Cancer Genome Atlas (TCGA) database for glioma patients. Through different expression analysis and lasso regression, further screening of core genes in the network was conducted, and a prognostic model was established. The sample was divided into two groups with high and low risk using this model. The RNA-seq data from the Chinese Glioma Genome Atlas (CGGA) database were used to further validate our prediction model. Then, we explored the difference in pathways enrichment between high-risk patients and low-risk patients and calculated the difference in immune microenvironment between the two groups. Finally, we used scRNA-seq data in the CGGA database to analyze the cell types in which the model gene is mainly enriched and predicted the cell types which saffron effected on.


  • Open Access

    Network pharmacology and experimental verification reveal the mechanism of safranal against glioblastoma (GBM)

    by Xiaobing Yang, Di Lu, Yanfei Sun, Tiandi Wei, Dulegeqi Man, Anbin Chen, Tao Luo, Feihu Zhao, Xuemeng Liu, Bo Cheng, et al.

    Introduction: Safranal is an active component of the traditional Tibetan medicine (TTM) saffron, which has potential anticancer activity.Methods and results: Here, we studied the therapeutic effect and mechanism of safranal on GBM. CCK-8, GBM-brain organoid coculture experiments and 3D tumour spheroid invasion assays showed that safranal inhibited GBM cell proliferation and invasion in vitro. Network pharmacology, RNA-seq, molecular docking analysis, western blotting, apoptosis, and cell cycle assays predicted and verified that safranal could promote GBM cell apoptosis and G2/M phase arrest and inhibit the PI3K/AKT/mTOR axis. In vivo experiments showed that safranal could inhibit GBM cell growth alone and in combination with TMZ.Conclusion: This study revealed that safranal inhibits GBM cell growth in vivo and in vitro, promotes GBM cell apoptosis and G2/M phase arrest, inhibits the PI3K/AKT/mTOR axis and cooperate with TMZ.


  • Open Access

    Correction: Procollagen-lysine 2-oxoglutarate 5-dioxygenase 2 promotes hypoxia-induced glioma migration and invasion

    by Yangyang Xu, Lin Zhang, Yuzhen Wei, Xin Zhang, Ran Xu, Mingzhi Han, Bing Huang, Anjing Chen, Wenjie Li, Qing Zhang, et al.

    [This corrects the article DOI: 10.18632/oncotarget.15581.].


  • Retracted
    Open Access

    [Retracted] Predicting Decreased Activities of Daily Living in Patients with Moyamoya Disease after Revascularization: Development and Assessment of a New Predictive Nomogram

    by Yani Zhao, Dongliang Yang, Gang Li, Peng Zhao, Xiaorong Luan, Haiyan Li

    The aim of this study was to develop and validate a nomogram model to predict the risk of decreased activities of daily living (ADLs) in patients with moyamoya disease (MMD) following revascularization. The nomogram model was constructed based on data from 292 patients with MMD that were treated at Qilu Hospital of Shandong University from January 2018 to June 2019. The prediction model was assessed using a dataset of 119 patients with MMD collected from July 2019 to June 2020. Patients were evaluated with a general information questionnaire and the Mini Mental Status Examination, Hospital Anxiety and Depression Scale, Social Support Rating Scale, and ADL Scale. Multivariable logistic regression analysis was applied to build a prediction model incorporating the features selected in the least absolute shrinkage and selection operator regression model. Discrimination, calibration, and clinical usefulness of the prediction model were assessed using receiver operating characteristic (ROC) curves, calibration plots, and decision curve analysis. Predictors contained in the nomogram included gender, age, monthly income, hypertension, and cognitive function and depression scores. The areas under the ROC curves of the training and testing datasets were 0.938 and 0.853, respectively. The prediction model displayed good calibration, and the decision curve analysis showed that it had a wide range of clinical applications. This novel predictive could be conveniently used to predict the risk of the decreased living activity ability in patients with MMD.


  • Open Access

    Epithelial membrane protein 1 promotes glioblastoma progression through the PI3K/AKT/mTOR signaling pathway

    by Lifeng Miao, Zheng Jiang, Jiwei Wang, Ning Yang, Qichao Qi, Wenjing Zhou, Zichao Feng, Wenjie Li, Qing Zhang, Bin Huang, et al.

    Glioblastoma multiforme (GBM) is the most malignant intracranial tumor. Although the affected patients are usually treated with surgery combined with radiotherapy and chemotherapy, the median survival time for GBM patients is still approximately 12‑14 months. Identifying the key molecular mechanisms and targets of GBM development may therefore lead to the development of improved therapies for GBM patients. In the present study, the clinical significance and potential function of epithelial membrane protein 1 (EMP1) in malignant gliomas were investigated. Increased EMP1 expression was associated with increasing tumor grade (P<0.001) and worse prognosis in patients (P<0.001) based on TCGA, Rembrandt and CGGA databases for human gliomas. In vitro, gene silencing of EMP1 in U87MG and P3 GBM (primary glioma) cells significantly inhibited tumor proliferation and invasion. In addition, it was revealed that activation of the PI3K/AKT/mTOR signaling pathway is the driving force of EMP1‑promoted glioma progression. Finally, it was demonstrated, using an intracranial GBM animal model, that EMP1 knockdown significantly inhibits tumor growth in vivo and increases overall survival in tumor‑bearing animals. Our research provides new insights into the molecular mechanisms underlying EMP1 knockdown‑mediated inhibition of GBM cell invasion and raises the possibility that targeting of EMP1 may represent a promising strategy for the treatment of GBM.


  • Open Access

    Procollagen-lysine 2-oxoglutarate 5-dioxygenase 2 promotes hypoxia-induced glioma migration and invasion

    by Yangyang Xu, Lin Zhang, Yuzhen Wei, Xin Zhang, Ran Xu, Mingzhi Han, Bing Huang, Anjing Chen, Wenjie Li, Qing Zhang, et al.

    Procollagen-lysine 2-oxoglutarate 5-dioxygenase 2 promotes hypoxia-induced glioma migration and invasion


  • Open Access

    A reproducible brain tumour model established from human glioblastoma biopsies

    by Jian Wang, Hrvoje Miletic, Per Ø Sakariassen, Peter C Huszthy, Hege Jacobsen, Narve Brekkå, Xingang Li, Peng Zhao, Sverre Mørk, Martha Chekenya, et al.

    Establishing clinically relevant animal models of glioblastoma multiforme (GBM) remains a challenge, and many commonly used cell line-based models do not recapitulate the invasive growth patterns of patient GBMs. Previously, we have reported the formation of highly invasive tumour xenografts in nude rats from human GBMs. However, implementing tumour models based on primary tissue requires that these models can be sufficiently standardised with consistently high take rates. In this work, we collected data on growth kinetics from a material of 29 biopsies xenografted in nude rats, and characterised this model with an emphasis on neuropathological and radiological features. The tumour take rate for xenografted GBM biopsies were 96% and remained close to 100% at subsequent passages in vivo, whereas only one of four lower grade tumours engrafted. Average time from transplantation to the onset of symptoms was 125 days ± 11.5 SEM. Histologically, the primary xenografts recapitulated the invasive features of the parent tumours while endothelial cell proliferations and necrosis were mostly absent. After 4-5 in vivo passages, the tumours became more vascular with necrotic areas, but also appeared more circumscribed. MRI typically revealed changes related to tumour growth, several months prior to the onset of symptoms. In vivo passaging of patient GBM biopsies produced tumours representative of the patient tumours, with high take rates and a reproducible disease course. The model provides combinations of angiogenic and invasive phenotypes and represents a good alternative to in vitro propagated cell lines for dissecting mechanisms of brain tumour progression.